wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38735477-DE15AE86-31D6-46BF-94DB-E5A52FB3BED4
Q38735477-DE15AE86-31D6-46BF-94DB-E5A52FB3BED4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38735477-DE15AE86-31D6-46BF-94DB-E5A52FB3BED4
Insights on the use of biosimilars in the treatment of inflammatory bowel disease.
P2860
Q38735477-DE15AE86-31D6-46BF-94DB-E5A52FB3BED4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38735477-DE15AE86-31D6-46BF-94DB-E5A52FB3BED4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5663443de078aef5dc901bccffe4b4009871a0f8
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.